MALIGNANCY OF GASTRIC ULCER DISEASE
DOI:
https://doi.org/10.55640/Keywords:
sign Malignancy of gastric ulcer disease forms Malignancy of gastric ulcer disease types Malignancy of gastric ulcer diseaseAbstract
The incidence of malignant gastric ulcer in relation to benign ulcer has been investigated and is approximately 6 per cent. The diagnosis of malignant ulcer may be possible at the first examination, but repeated examinations are often necessary before malignancy is suspected. The lesser curvature of the body of the stomach is the most common site, followed closely by the region of the angulus and the pylorus.
The criteria used in the past have been critically assessed and certain modifications are necessary when considering the diagnosis of a malignant ulcer. Size is a very variable feature. Convergence of rugal folds may occur and may extend up into the edge of the ulcer. Mistakes cannot be avoided when extensive fibrosis surrounds an old-standing peptic ulcer, but this possibility should not deter the radiologist from reporting the possibility of a malignant ulcer, as he will prove to be much more often correct than wrong. It is much better to operate on a benign ulcer than to miss the chance of early surgical removal of a malignant ulcer.
Downloads
References
1.Saodat, A., Vohid, A., Ravshan, N., & Shamshod, A. (2020). MRI study in patients with idiopathic cokearthrosis of the hip joint. International Journal of Psychosocial Rehabilitation, 24(2), 410-415.
2.Axmedov, S. J. (2023). EFFECTS OF THE DRUG MILDRONATE. Innovative Development in Educational Activities, 2(20), 40-59.
3.Jamshidovich, A. S. (2023). ASCORBIC ACID: ITS ROLE IN IMMUNE SYSTEM, CHRONIC INFLAMMATION DISEASES AND ON THE ANTIOXIDANT EFFECTS. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 3(11), 57-60.
4.Jamshidovich, A. S. (2023). THE ROLE OF THIOTRIAZOLINE IN THE ORGANISM. Ta'lim innovatsiyasi va integratsiyasi, 9(5), 152-155.
5.Jamshidovich, A. S. (2023). HEPTRAL IS USED IN LIVER DISEASES. ОБРАЗОВАНИЕ НАУКА И ИННОВАЦИОННЫЕ ИДЕИ В МИРЕ, 35(3), 76-78.
6.Jamshidovich, A. S. (2023). EFFECT OF TIVORTIN ON CARDIOMYOCYTE CELLS AND ITS ROLE IN MYOCARDIAL INFARCTION. Gospodarka i Innowacje., 42, 255-257.
7.Jamshidovich, A. S. (2024). NEUROPROTECTIVE EFFECT OF CITICOLINE. EUROPEAN JOURNAL OF MODERN MEDICINE AND PRACTICE, 4(1), 1-4.
8.Jamshidovich, A. S. (2024). THE ROLE OF TRIMETAZIDINE IN ISCHEMIC CARDIOMYOPATHY. Journal of new century innovations, 44(2), 3-8.
9.Jamshidovich, A. S. (2024). ВСЕ ЭФФЕКТЫ ПРЕПАРАТА ИМУДОН. TADQIQOTLAR, 31(2), 39-43.
10.Jamshidovich, A. S. (2024). SPECIFIC FEATURES OF THE EFFECT OF THE HEPARIN DRUG. TADQIQOTLAR, 31(2), 34-38.
11.Jamshidovich, A. S. (2024). ЭФФЕКТИВНОЕ ВОЗДЕЙСТВИЕ ПРЕПАРАТА КЕЙВЕР. Ta'lim innovatsiyasi va integratsiyasi, 15(3), 137-143.
12.Namozov, E. (2024). KЛИНИКО-МОРФОЛОГИЧЕСКИЕ ФОРМЫ РАКА МОЧЕВОГО ПУЗЫРЯ. Modern Science and Research, 3(12), 911-914.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India